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IL-10 is one of the most important anti-
inflammatory cytokines and plays an especially 
critical role in the intestine. The role of IL-10 
in the gut is underscored by the high expression 
of IL-10 by intestinal lymphocytes (Kamanaka   
et al., 2006). Furthermore, IL-10 KO mice de-
velop spontaneous colitis (Kühn et al., 1993), 
which demonstrates that IL-10 is essential for 
the maintenance of the immune homeostasis in 
the intestine.
The key target cell of IL-10 is considered to 
be the APC. Thus, the profound reduction of 
the Th1 response that is mediated by IL-10 was 
concluded to be indirect, being mediated by 
inhibition  of APCs  (Fiorentino  et  al.,  1991; 
Ding and Shevach, 1992) and resulting from 
down-regulation of NO production (Gazzinelli 
et al., 1992) and costimulatory cytokines and 
receptors such as IL-12 and CD80/CD86, re-
spectively, in APCs (Ding et al., 1993). Direct 
effects of IL-10 on T cells have been less well 
defined, although inhibitory effects of IL-10 on 
T cells have been reported using human T cells 
(Taga et al., 1993; Schandené et al., 1994).
To address immune-regulatory mechanisms 
in the gut, an adoptive transfer model, which 
employs immune-deficient hosts, has been de-
veloped and is widely used (Powrie et al., 1994). 
In this model, naive CD45RBhi CD4-positive 
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The role of direct IL-10 signaling in different T cell subsets is not well understood. To 
address this, we generated transgenic mice expressing a dominant-negative IL-10 receptor 
specifically in T cells (CD4dnIL-10R). We found that Foxp3-depleted CD45RBlo (regulatory 
T cell [Treg cell]–depleted CD45RBlo) but not CD45RBhi CD4+ T cells are controlled directly 
by IL-10 upon transfer into Rag1 knockout (KO) mice. Furthermore, the colitis induced by 
transfer of Treg cell–depleted CD45RBlo CD4+ T cells into Rag1 KO mice was characterized 
by reduced Th1 and increased Th17 cytokine messenger RNA levels in the colon as compared 
with the colitis induced by transfer of CD45RBhi T cells. In contrast to the CD45RBhi transfer 
colitis model, in which IL-22 is protective, we found that T cell–derived IL-22 was patho-
genic upon transfer of Treg cell–depleted CD45RBlo T cells into Rag1 KO mice. Our results 
highlight characteristic differences between colitis induced by naive (CD45RBhi) and mem-
ory/effector (Treg cell–depleted CD45RBlo) cells and different ways that IL-22 impacts 
inflammatory bowel disease.
©  2011  Kamanaka  et  al.  This  article  is  distributed  under  the  terms  of  an   
Attribution–Noncommercial–Share  Alike–No  Mirror  Sites  license  for  the  first 
six months after the publication date (see http://www.rupress.org/terms). After   
six months it is available under a Creative Commons License (Attribution–
Noncommercial–Share Alike 3.0 Unported license, as described at http://creative-
commons.org/licenses/by-nc-sa/3.0/).
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e1028 IL-10 signals in T cells protect against colitis | Kamanaka et al.
T cells at least at higher concentrations (Fig. S1 C). Stimula-
tion of the T cells with anti-CD3 and CD28 antibodies in the 
presence of APCs enhanced the surface expression of IL-10R 
after 24–48 h in each population (Fig. S1, A and B). These re-
sults show that functional IL-10R is expressed by all CD4   
T cell subsets both in the steady-state and after activation.
Generation of IL-10R dominant-negative TG mice
To analyze the role of IL-10 signaling in T cells, we generated 
mice in which IL-10 signaling is blocked in a cell lineage–
specific manner. We used the same combination of the CD4 
promoter and 3 untranslated region/polyA sequences that 
we used previously in TGF- RII dominant-negative TG 
mice (Gorelik and Flavell, 2000) to generate IL-10R domi-
nant-negative mice (CD4dnIL-10R mice; Fig. 1 A). As re-
ported previously, this promoter fragment lacks the regulatory 
element, which suppresses the expression of the transgene in 
CD8 T cells (Sawada et al., 1994). Consequently, the transgene   
is expressed in both CD4+ and CD8+ T cells. We obtained 
eight lines of TG mice. Of these lines, two had significantly 
higher transgene expression. As both the expression level and 
the initial analysis of the phenotype did not differ between 
these two lines, we chose one of these TG lines for further 
experiments  and  backcrossed  this  to  the  C57BL/6  back-
ground for >12 generations. TG mice developed normally 
and were fertile. They did not develop spontaneous intestinal 
inflammation even after they were backcrossed for >10 gen-
erations to the NOD/ShiLtj or BALB/c backgrounds.
First, we determined the cell surface expression levels of 
the transgene-encoded IL-10R on lymphocytes to confirm 
the specific expression of the IL-10R dominant-negative 
gene product in T cells. Of note, the antibody used for these ex-
periments binds to both the TG and the WT IL-10R. The 
IL-10R levels on the surface of CD4 and CD8 T cells were 
found to be high in the TG mice (Fig. 1 B). As endogenous 
IL-10R messenger RNA (mRNA) was not altered in the 
TG T cells (unpublished data), the high IL-10R expression 
on T cells detected in this experiment was inferred to be the 
result of the expression of the TG dominant-negative recep-
tor. The IL-10R expression level in B cells was slightly ele-
vated in the TG mice. This is in line with the report by others 
that the CD4 promoter fragment also expresses weakly in B cells 
(Sawada et al., 1994). However, there was no significant in-
crease in IL-10R expression in CD4+ or CD8+ CD11c+ 
dendritic cells from the spleen (Fig. 1 C) or CD11b+ spleen 
and peritoneal macrophages (not depicted).
To functionally validate the specificity of the blockade of 
IL-10 signaling in this TG model, we determined the phos-
phorylation status of Stat3 in T cells after incubation with ex-
ogenous IL-10 in vitro. In T cells from the TG mice, Stat3 
phosphorylation was almost completely blocked, whereas in 
B cells, its phosphorylation was not affected (Fig. 1 D). Thus, 
T cells but not B cells from CD4dnIL-10R mice are poorly 
responsive to IL-10 signaling.
To confirm the blockade of IL-10 signaling in T cells, we 
measured the proliferation of thymocytes in response to IL-10 in 
T cells induce colitis upon transfer into Rag1 KO mice. The 
development of colitis could be prevented by coinjection of 
CD4+ CD45RBlo cells; furthermore, this inhibition appeared 
to be IL-10 dependent, as prevention of colitis was abolished 
by the administration of neutralizing anti–IL-10R antibody 
(Asseman et al., 1999). Thereafter it was shown that the CD4+ 
CD45RBlo  population  contains  CD25+Foxp3+  regulatory   
T cells (Treg cells), which are responsible for the regulatory 
activity of this subset (Asseman et al., 2003). However, Treg 
cells do not need to secrete IL-10 for this suppression of dis-
ease (Asseman et al., 2003). In contrast, CD45RBlo CD4+  
T cells seem to be regulated in some way by IL-10 upon 
transfer into RAG1 KO mice, as anti–IL-10R antibody treat-
ment induces colitis in recipients of CD45RBlo CD4+ T cells 
(Asseman et al., 2003). However, based on this study, it was 
not clear whether IL-10 acts directly on CD45RBlo Foxp3+ 
(nTreg cell), CD45RBlo Foxp3 (Treg cell–depleted CD45RBlo) 
cells, or other cells present in the Rag1 KO host such as APCs, 
which are generally considered to be targets of IL-10 action.
In this study, we aimed to investigate direct effects of 
IL-10 on T cells. To that end, we generated mice in which IL-10 
signaling is specifically blocked in T cells by transgenic (TG) 
overexpression of a dominant-negative IL-10R under the 
CD4 promoter (CD4dnIL-10R mice). We found that IL-10 
signaling in T cells is dispensable for the maintenance of the 
immune homeostasis in mice kept under specific pathogen-
free conditions. However, in contrast to CD4+ CD45RBhi 
cells, TG Treg  cell–depleted  CD4+  CD45RBlo  cells  caused 
more severe disease upon transfer into Rag1 KO mice com-
pared with respective WT cells and also escaped the control 
exerted by nTreg cells. Further comparison of the colitis in-
duced  by  CD4+  CD45RBhi  and Treg  cell–depleted  CD4+ 
CD45RBlo cell populations revealed that colitis induced by 
the transfer of CD4+ CD45RBhi T cells into Rag1 KO 
mice exhibits a higher Th1 response compared with Treg cell– 
depleted  CD4+  CD45RBlo  cells,  which  showed  increased 
Th17 response. Furthermore, the intestinal pathology that de-
velops upon transfer of Treg cell–depleted CD4+ CD45RBlo  
T cells depended on T cell–derived IL-22, whereas in con-
trast, IL-22 was protective in the CD45RBhi model. The in-
testinal pathology induced by transfer of Treg cell–depleted 
CD4+ CD45RBlo cells was characterized by mucosal thick-
ening and was associated with increased proliferation of colon 
epithelial cells, which was induced by IL-22.
RESULTS
Expression of IL-10R in T cell subsets
As the role of IL-10 signaling in T cells is not well characterized, 
we first determined the expression levels of IL-10R on the sur-
face of naive (CD45RBhi), memory/effector (Treg cell–depleted 
CD45RBlo), and nTreg CD4 T cells (see Fig. 3 A). IL-10R ex-
pression was detectable in all of these cell subsets before 
any stimulation, albeit at very low levels (Fig. S1, A and B). 
However, the expression of the receptor was confirmed to be 
functional because IL-10 stimulation led to phosphorylation 
of Stat3 in CD45RBhi and Treg cell–depleted CD45RBlo CD4 JEM VOL. 208, May 9, 2011 
Article
1029
the TG mouse as previously described (MacNeil et al., 1990). 
Thymocytes from WT mice proliferated vigorously when stim-
ulated with IL-10, whereas those from CD4dnIL-10R mice 
were much less responsive to IL-10 (Fig. 1 E). In B cells, which 
are known to up-regulate MHC class II in response to IL-10, as 
expected, we did not observe any difference in the up-regulation 
of these molecules (unpublished data). Thus, IL-10 signaling is 
specifically blocked in T cells in this TG model.
The IL-6–Stat3 pathway was not affected by the blockade 
of IL-10 signaling
IL-6 is an important factor that together with TGF- induces 
Th17 cells (Veldhoen et al., 2006). IL-6 uses the Stat3 pathway, 
which is also activated by IL-10 signaling (Zhong et al., 1994). 
Thus, we asked whether IL-6–mediated Stat3 phosphorylation 
is affected by the blockade of IL-10 signaling. However, the 
phosphorylation of Stat3 by IL-6 was unaffected in TG CD4   
T cells (Fig. S2 A). Additionally, the differentiation of Th17 cells 
in vitro by IL-6 and TGF- also did not present any difference 
between WT and TG CD4 T cells (Fig. S2 B). Therefore, the 
TG overexpression of a dominant-negative IL-10R does not 
seem to alter the IL-6–Stat3 signaling pathway.
Direct IL-10 signaling in CD4+ CD45RBlo T cells controls 
colitis development
To understand the role of direct IL-10 signaling in CD4 T cells 
in vivo, we used the colitis model induced by adoptive transfer of 
CD4+ T cells. First, we isolated CD4+ T cells from the spleen and 
adoptively  transferred  them  into  syngeneic  Rag1-deficient 
mice. Unfractionated CD4 T cells containing CD45RBhi, Treg 
cell–negative CD45RBlo, and nTreg cells from WT mice were 
not pathogenic, whereas transfer of the CD4 T cells from 
CD4dnIL-10R mice caused colitis (Fig. 2, A and B).
To further identify which CD4 T cell population was re-
sponsible for colitis development upon transfer of these TG 
T cells, we fractionated the CD4 T cells into CD45RBhi and 
CD45RBlo cells; the latter population consists of memory/effector   
CD4 T cells and nTreg cells (Fig. 2 C). Rag1 KO mice adop-
tively transferred with CD4+ CD45RBhi cells from WT and TG 
mice both developed colitis rapidly with a similar rate of loss of 
body mass (Fig. 2 D). In contrast, Rag1 KO mice transferred 
with total CD4+ CD45RBlo cells from WT mice did not de-
velop colitis, whereas the corresponding cells from the TG mice 
precipitated colitis in recipient mice (Fig. 2, E–G). Histological 
analysis confirmed the development of colitis in TG CD45RBlo 
recipient mice (Fig. 2, F and G). These results indicate that IL-10 
signaling in T cells is required to control CD45RBlo but not 
CD45RBhi cells upon transfer into Rag1 KO mice.
Figure 1.  Generation of dominant-negative IL-10R TG mice.  
(A) Construct used for the generation of IL-10R dominant-negative 
mice. Signal peptide (SP), extracellular (EX), transmembrane (TM), and 
intracellular (IC) regions are shown. Ex1 and Ex2 are the exons of the CD4 
promoter region. (B) Expression analysis of IL-10R in the dominant-
negative TG mice in splenocytes. IL-10R expression (solid lines) was ana-
lyzed using flow cytometry. PE-conjugated hamster IgG1 was used as a 
control (dotted lines). (C) Relative mean fluorescence intensity (MFI) from 
WT mice (closed bars) and TG mice (open bars) shown as a fold increase 
compared with the control staining. (D) Western blot analysis of Stat3 
and phospho-Stat3 (p-Stat3) in CD4 T cells and B cells incubated with the 
indicated concentration of IL-10. (E) CD4CD8 double–negative cells and 
CD4 single–positive cells were isolated from the thymus of WT and TG 
mice using FACS, and 105 cells were incubated with or without 100 ng/ml 
IL-10 for 5 d (indicated as + and ). [3H]thymidine was added during the 
last 16 h of culture, and 3H uptake was measured (mean ± SD of the trip-
licates). Results are representative of two experiments.
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trols Foxp3+CD45RBlo or Foxp3CD45RBlo or CD45RBhi 
cells, we performed adoptive transfer of these three separate 
populations into Rag1 KO mice. Transfer of WT or TG nTreg 
cells caused neither loss of mass nor intestinal disease (Fig. 3 B). 
When  CD4+  CD45RBhi T  cells  from WT  or TG  mice 
were adoptively transferred, both cell populations induced 
similar rapid colitis (Fig. 3 B). In contrast, Rag1 KO mice that 
received TG CD4+ CD45RBlo T cells lost mass more dramat-
ically and induced more severe colitis compared with WT 
(Fig. 3 B; P < 0.05). We next tested whether IL-10 signaling 
in Treg cells is required for their in vivo suppressive function. 
Disease caused by transfer of CD4+ CD45RBhi T cells could 
be prevented by coinjection of both WT and TG Treg cells 
(Fig.  3  C). Additionally, Treg  cell–mediated  suppression  of 
CD4+ CD45RBhi T cells was not dependent on IL-10 signal-
ing in CD4+ CD45RBhi T cells (Fig. 3 D). In contrast, colitis 
caused by transfer of TG Treg cell–depleted CD4+ CD45RBlo 
Foxp3CD45RBlo cells, which cannot respond to IL-10, 
escape control by Treg cells
Previously, we generated internal ribosomal entry site RFP 
Foxp3 knockin reporter mice (FIR mice; Wan and Flavell, 
2005), which enable the identification and isolation of Foxp3-
expressing cells without fixation. This reporter system is more 
advantageous than anti-CD25 mAb staining because CD25 
is also expressed in Foxp3-negative activated cells and some 
Foxp3-positive cells are CD25 negative. By using these Foxp3 
knockin reporter mice, CD4+ CD45RBlo cells could be fur-
ther fractionated into Foxp3+CD45RBlo cells (nTreg cells) and 
Foxp3CD45RBlo (Treg cell–depleted CD45RBlo) cells. The 
gates were set for these populations as shown in Fig. 3 A. The 
frequency of each population did not differ significantly be-
tween WT and TG mice. As shown in Fig. 2, IL-10 signaling in 
total CD4 T cells was required to control them upon transfer 
into Rag1 KO mice. To identify whether IL-10 directly con-
Figure 2.  IL-10 controls CD45RBlo cells upon transfer into Rag1 KO mice. (A) 106 CD4 T cells were adoptively transferred into Rag1 KO mice, and 
the weight changes were monitored (TG, dotted line with open circles; WT, solid line with closed circles; TG, n = 5; WT, n = 5; *, P < 0.05). † indicates the 
experiment was stopped because of the severe colitis in mice receiving CD4dnIL-10R T cells. (B) The histological colitis scores of colons after the adop-
tive transfer of total CD4+ T cells (*, P < 0.05). (C) Representative dot plots showing the sorting gates for CD45RBhi or CD45RBlo cells in CD4 T cells from 
WT and CD4dnIL-10R mice. (D) 5 × 105 CD4+ CD45RBhi cells were adoptively transferred into Rag1 KO mice, and weight changes were monitored (TG, 
dotted line with open circles; WT, solid line with closed circles). (E) 5 × 105 CD4+ CD45RBlo cells were adoptively transferred into Rag1 KO mice, and 
weight changes were monitored (open circles, mice transferred with TG cells, n = 4; closed circles, mice transferred with WT cells, n = 4; ***, P < 0.0001). 
(A, D, and E) Error bars represent mean ± SEM. (F and G) Histological findings (G) and colitis score (F) of Rag1 KO transferred with CD4+ CD45RBlo T cells  
8 wk after the transfer (WT, n = 14; TG, n = 12; ***, P < 0.0001). Results are representative of at least two independent experiments. Bars, 1,000 µm.JEM VOL. 208, May 9, 2011 
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T cells could not be prevented by nTreg cells (Fig. 3 E). These 
results indicated that direct IL-10 signaling is required to con-
trol Treg cell–depleted CD45RBlo but not CD45RBhi CD4+ 
T cells.
In vitro suppression of CD45RBhi and Foxp3CD45RBlo CD4+ 
T cells by nTreg cells
To further investigate the mechanism of suppression by nTreg 
cells, we used the well characterized in vitro suppression assay 
system. As IL-23 plays an important role for the development 
of intestinal pathology in mice (Ahern et al., 2010) and 
humans (Duerr et al., 2006), we combined this assay with the 
addition of IL-23. First, we used CD4+ CD45RBhi T cells 
from WT or TG mice as responder cells and added varying 
numbers of WT nTreg cells to the culture wells. The suppres-
sion of proliferation by nTreg cells was comparable using re-
sponder WT or TG CD4+ CD45RBhi T cells as responders 
(Fig. 4, top). This suppressive effect was unaffected by the ad-
dition of IL-23. Second, we used Treg cell–depleted CD4+ 
CD45RBlo T cells from WT and TG mice as responder cells. 
nTreg cells again effectively suppressed Treg cell–depleted CD4+ 
CD45RBlo T cells. However, the addition of IL-23 rendered 
the cells more resistant to suppression by nTreg cells. This es-
cape from suppression through IL-23 was significantly higher 
for the TG T cells than for WT cells (Fig. 4, middle). Of note, 
there was no difference in Il23r mRNA expression between WT 
and TG Treg cell–depleted CD4+ CD45RBlo T cells (Fig. S3 A). 
Lastly, we compared the efficiency of suppression by WT and 
TG nTreg cells using WT CD4+ CD45RBhi T cells as respond-
ers. nTreg cells from WT and TG mice could both suppress 
proliferation similarly in the presence or absence of IL-23. 
These results were consistent with the findings from adoptive 
transfer experiments and suggest that the blockade of IL-10 
signaling may enable the Treg cell–depleted CD4+ CD45RBlo 
T cells to escape nTreg cell suppression in the presence of IL-23. 
However, the addition of IL-23 did not completely abrogate 
the suppressive capacity of nTreg cells, indicating that other 
microenvironmental factors may also contribute to the in-
creased  pathogenicity  of  TG  Treg  cell–depleted  CD4+ 
CD45RBlo T cells upon transfer into Rag1 KO mice.
Increased pathogenicity of TG Treg cell–depleted CD4+ 
CD45RBlo T cells is caused by a cell-intrinsic effect
We next aimed to determine whether TG Treg cell–depleted 
CD4+ CD45RBlo T cells demonstrated a more pathogenic 
phenotype compared with WT before the transfer into Rag1 
KO mice. To that end, we characterized the cytokine status of 
TG and WT Treg cell–depleted CD4+ CD45RBlo T cells be-
fore the adoptive transfer into Rag1 KO mice. We could not 
find any significant difference in IL-17A, IFN-, TNF-, or 
IL-10 mRNA expression between freshly isolated TG and 
WT Treg cell–depleted CD4+ CD45RBlo T cells (Fig. S3 A). In 
line with this observation, we did not find a significant difference 
in the frequency of IL-17A–, IFN-–, or TNF-–producing Treg 
cell–depleted  CD4+  CD45RBlo T  cells  using  intracellular 
cytokine staining after 3 h of activation or 4 d of stimulation 
Figure 3.  Foxp3CD45RBlo T cells are controlled by nTreg cells via 
IL-10. (A) Representative dot plots showing the sorting gates for WT 
and CD4dnIL-10R CD4 T cell subsets. (B) 3 × 105 nTreg cells, CD45RBhi, 
and Foxp3CD45RBlo (Treg cell–depleted CD45RBlo) CD4+ T cells isolated 
from WT and CD4dnIL-10R mice were transferred into Rag1 KO mice. 
Weight loss and histological colitis score 6 wk after the transfer in the 
case of CD45RBhi cell and 12 wk after transfer in the case of nTreg cells 
and Treg cell–depleted CD45RBlo cells are shown. (C) WT and TG nTreg cells 
were transferred either alone or together with WT CD45RBhi cells into 
Rag1 KO mice. (D) WT or TG CD45RBhi cells were transferred together 
with WT nTreg cells into the Rag1 KO mice. WT CD45RBhi cells were also 
transferred alone as a control. (E) WT or TG Treg cell–depleted CD45RBlo 
cells were transferred together with WT or TG nTreg cells into Rag1 KO 
mice. (C–E) Weight change and colitis score 12 wk after the transfer are 
shown. (B–E) † indicates mice that had to be sacrificed because of the 
severity of disease. Each dot represents one animal. Horizontal bars 
indicate the mean. The results shown are representative of three experi-
ments. *, P < 0.05; **, P < 0.01.1032 IL-10 signals in T cells protect against colitis | Kamanaka et al.
marrow chimera system. For this experiment, we used CD25 
as a marker for Treg cells. Through this approach, we were 
therefore able to isolate WT and TG CD4+CD25CD45RBlo 
T cells, which developed in the same in vivo environment. 
This system allowed us to elucidate whether the increased 
pathogenicity  of TG Treg  cell–depleted  CD4+  CD45RBlo  
T cells was caused by a cell-intrinsic effect (by the blockade 
of IL-10R on T cells) or cell-extrinsic effect (by the in vivo 
environment during T cell development). We generated bone 
marrow chimeras using mixed bone marrow from TG and 
WT mice injected into irradiated CD45.1 Rag1 KO mice 
(Fig. 5 A). 12 wk later, the cells were recovered from these 
mice and analyzed. The frequency of CD45.1+ and CD45.2+ 
CD4+ T  cells,  as  well  as  the  frequency  and  number  of 
CD4+CD25CD45RBlo within CD45.1+ WT and CD45.2+ 
TG CD4 T cells, recovered from the chimeric mice was not dif-
ferent (Fig. 5 B and not depicted). We next isolated CD45.1+  
and CD45.2+ CD4+CD25CD45RBlo cells and transferred 
these cells into another Rag1 KO recipient. Rag1 KO mice, 
which received TG CD45.2+CD4+CD25CD45RBlo T cells, 
lost more body weight than the corresponding mice that re-
ceived WT CD45.1+CD4+CD25CD45RBlo cells (Fig. 5 C). 
The severity of colitis assessed by endoscopic analysis also 
indicated that the TG Treg cell–depleted CD4+ CD45RBlo T cells 
induced more severe colitis compared with WT cells (Fig. 5, 
D and E). Our results therefore demonstrate that blockade of 
IL-10 signaling in Treg cell–depleted CD4+ CD45RBlo T cells 
induces more severe colitis in the adoptive transfer model 
into the Rag1 KO mice. This seems to be mediated via a   
T cell–intrinsic effect.
To further prove a cell-intrinsic effect, we performed com-
petitive adoptive transfer of CD45RBhi and Treg cell–depleted 
Foxp3CD45RBlo CD4+ T cells from WT and TG mice. 
CD45.1 was again used as a marker to distinguish the donor 
WT (CD45.2+) or TG (CD45.1+/CD45.2+) T cells that were 
coinjected into Rag1 KO mice (CD45.1+; Fig. S4 A). After   
1 mo, proliferation of the donor T cells was measured by 
BrdU uptake. The CD45RBhi CD4+ T cells from WT and TG 
mice proliferated similarly (Fig. S4 B, top left). However, Treg 
cell–depleted CD4+ CD45RBlo T cells from TG mice prolif-
erated more than those from WT mice (Fig. S4 B, left). Support-
ing this observation, the ratio of WT versus TG donor CD4+ 
T cells was almost equal if CD45RBhi cells were transferred, but 
more than twice the number of TG cells was recovered when 
Treg cell–depleted CD45RBlo T cells were transferred (Fig. S4 C). 
This  indicates  that  IL-10  signaling  in Treg  cell–depleted 
CD45RBlo cells but not CD45RBhi CD4+ T cells is required 
to control their proliferation. Additionally, these data again 
indicate a cell-intrinsic rather than a cell-extrinsic effect.
Cytokine profiles in colitis induced by CD45RBhi and Treg 
cell–depleted CD45RBlo CD4+ T cells
To further understand the characteristics of the CD45RBhi 
and Treg cell–depleted CD45RBlo CD4+ T cell transfer models 
and the effect of the blockade of IL-10 signaling, we measured 
the levels of cytokine mRNAs in the colons of diseased mice, 
in vitro (Fig. S3 B). Additionally, ROR-t expression at both 
the protein and mRNA levels was comparable between TG 
and WT Treg cell–depleted CD4+ CD45RBlo T cells (Fig. S3, 
A and C) before the transfer.
To ensure that the increased pathogenicity of TG CD4+ 
CD45RBlo T cells was not caused by a difference in the in 
vivo environment of TG mice, which might lead to an   
increase of flora-reactive potentially pathogenic cells in the Treg 
cell–depleted CD4+ CD45RBlo T cell pool, we used a bone 
Figure 4.  IL-10 signaling in Foxp3-depleted CD45RBlo T cells is 
important for their complete suppression by nTreg cells in the pres-
ence of IL-23 in vitro. WT or TG CD45RBhi cells (top), WT or TG 
CD4+Foxp3CD45RBlo (Treg cell–depleted CD45RBlo) cells (middle), or WT 
CD45RBhi cells (bottom) were cultured with WT or TG nTreg cells in the 
presence or absence of IL-23. [3H]thymidine was added during the last 16 h 
of culture, and 3H uptake was measured. Results are representative of 
three experiments. Error bars represent mean ± SEM. *, P < 0.05.JEM VOL. 208, May 9, 2011 
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which received either of these cell populations derived from 
WT animals. Of note, even WT Treg cell–depleted CD45RBlo 
CD4+ T cells caused colitis upon transfer into Rag1 KO mice 
after 10–13 wk (see Fig. 8).
IFN- was similarly highly expressed in the CD45RBhi  
T cell transfer model developed both by WT and TG cells 
(Fig. 6 A). However, the expression of IFN- in the WT Treg 
cell–depleted CD4+ CD45RBlo T cell transfer model was less 
than in the CD45RBhi cell transfer model. Treg cell–depleted 
CD4+ CD45RBlo T cells from TG mice caused higher ex-
pression of IFN- in the colon of the recipient than mice that 
received the corresponding WT cells. IL-17A expression was 
higher in the mice that received Treg cell–depleted CD4+ 
CD45RBlo T cells than those that received CD45RBhi CD4+ 
T cells. Furthermore, the mice that received TG Treg cell– 
depleted CD4+ CD45RBlo T cells showed higher expression 
of IL-17A than mice that received corresponding WT cells. 
These results indicate that, in general, CD45RBhi CD4+  
T cell–induced colitis is characterized by a greater Th1 re-
sponse, whereas Treg cell–depleted CD4+ CD45RBlo T cells 
induce a more Th17-driven colitis. Th17 cells are also known 
to produce IL-17F and IL-22. Because the Treg cell–depleted 
CD45RBlo colitis showed a more pronounced Th17 response, 
we measured these cytokines in the colons; Rag1 KO mice 
that received Treg cell–depleted CD4+ CD45RBlo T cells showed 
increased mRNA levels of these cytokines in the colon after 
development of disease compared with CD45RBhi cells. Also, 
the blockade of IL-10 signaling enhanced this effect (Fig. 6 A). 
These results suggest again that Treg cell–depleted CD45RBlo 
T cells generated a more Th17 cell–mediated colitis com-
pared with CD45RBhi CD4+ T cells. The blockade of IL-10 
signaling in Treg cell–depleted CD45RBlo led to more severe 
disease in the Rag1 KO recipient (Fig. 3), and in line with 
that, we also found higher IL-17F and IL-22 mRNA levels in 
their colons. G-CSF was reported to be induced in epithelial 
cells by IL-17A (Ye et al., 2001). According to our results, G-CSF 
mRNA  expression  showed  a  similar  pattern  to  the  other 
Th17 cytokine mRNA levels, which underlined the distinct 
cytokine patterns of the colitis induced with CD45RBhi and 
Treg cell–depleted CD45RBlo CD4+ T cells.
To further confirm that transfer of Treg cell–depleted 
CD4+ CD45RBlo T cells into Rag1 KO mice led to a more 
Th17 cell–mediated colitis, we recovered CD4 T cells from 
the  colons  of  Rag1  KO  mice  adoptively  transferred  with 
CD45RBhi and Treg cell–depleted CD45RBlo CD4+ T cells. 
Consistent with the higher Th17 cytokine mRNA levels, we 
found a higher percentage of ROR-t–expressing cells in the 
mice that received Treg cell–depleted CD45RBlo cells com-
pared with those receiving CD45RBhi CD4+ T cells (Fig. 6 B, 
top vs. bottom). Again, the mice that received TG Treg cell–
depleted CD4+ CD45RBlo T cells showed a further increase 
in the percentage of ROR-t–expressing T cells compared 
with WT (Fig. 6 B, bottom). The absolute number of ROR-
t–expressing cells recovered from the colons confirmed the 
more pronounced development of ROR-t–expressing T cells 
from the TG Treg cell–depleted CD4+ CD45RBlo T cells than 
Figure 5.  Increased pathogenicity of TG CD25CD45RBlo cells is 
caused by a cell-intrinsic effect. (A) Mixed bone marrow chimeras 
were generated by the cotransfer of bone marrow derived from CD45.1 
WT and CD45.2 WT or CD45.2 TG mice into sublethally irradiated CD45.1 
Rag1 KO mice. 12 wk after the transfer, CD4+CD25CD45RBlo (Treg cell–
depleted CD45RBlo) expressing either CD45.1 or CD45.2 were isolated 
from the spleen of chimeric mice and transferred into another Rag1 KO 
recipient (2 × 105). (B) Frequency of CD45.2- and CD45.1-positive cells 
within CD4 T cells and of CD4+CD25CD45RBlo cells gated on 
CD4+CD45.1 or CD4+CD45.2 cells in the spleen of chimeric mice 12 wk after 
transfer. (C and D) Mass loss (C) and endoscopic colitis score (D) of Rag1 
KO recipients 8 and 12 wk after the transfer of CD4+CD25CD45RBlo 
cells isolated from the mixed bone marrow chimera (WT control, Rag1 
KO mice receiving CD45.2 or CD45.1 WT cells isolated from the WT con-
trol chimera). (E) Representative endoscopic findings 12 wk after the 
transfer. Results were combined from two independent experiments. 
Each dot represents one animal. Error bars represent mean ± SEM.  
*, P < 0.05; **, P < 0.01.1034 IL-10 signals in T cells protect against colitis | Kamanaka et al.
mice, which had received TG Treg cell–depleted CD4+ 
CD45RBlo T cells compared with WT cells. Further 
complexity may derive from the fact that IL-17A/
IFN- double–producing CD4 T cells Th17 + Th1 
have been observed in colitis models and human in-
flammatory bowel disease (IBD) patients (Annunziato 
et al., 2007; Ahern et al., 2010). Further studies are re-
quired to understand which of these complex T cell 
subsets are modulated directly via IL-10.
Intestinal pathology induced by Treg cell–depleted 
CD4+ CD45RBlo T cells requires IL-22
We previously reported a protective function of both 
IL-17A and IL-22 in the CD45RBhi colitis model (Zenewicz 
et al., 2008; O’Connor et al., 2009). As shown in Fig. 6, trans-
fer of Treg cell–depleted CD45RBlo CD4 T cells causes a more 
Th17 type of colitis compared with CD45RBhi CD4+ T cells. 
However, the role of IL-22 and IL-17A in this model was   
unclear. To analyze the role of these cytokines in the Treg cell–
depleted CD4+ CD45RBlo colitis, we performed adoptive 
transfer  experiments  using  IL-17A–  or  IL-22–deficient   
T cells as donor cells. We again used CD25 as a marker to   
deplete Treg  cells  within  the  CD45RBlo  CD4+ T  cells. 
CD25CD45RBlo cells were purified as shown in Fig. S5 A. 
Transfer of IL-22 KO but not IL-17A KO Treg cell–depleted 
CD4+ CD45RBlo T cells into Rag1 KO caused a reduced loss 
of body mass and histological colitis score compared with the 
mice that received WT cells (Fig. S5, B and C). We next aimed 
to study the role of T cell–derived IL-22 in more detail. First, 
we repeated that upon transfer into Rag1 KO mice, IL-22 KO 
Treg cell–depleted CD4+ CD45RBlo T cells cause less disease 
based on mass loss, colon length, and endoscopic and histo-
logical colitis score compared with WT (Fig. 8, A–D).
Further  analyses  of  the  cytokine  mRNA  levels  of  the   
colon showed that colitis induced with IL-22 KO Treg cell– 
depleted CD4+ CD45RBlo T cells was manifested by reduced 
WT (Fig. 6 C). Of note, the percentage of ROR-t–expressing 
cells before the transfer into Rag1 KO mice was very low and 
about  the  same  in WT  and TG Treg  cell–depleted  CD4+ 
CD45RBlo T cells (Fig. S3 C), indicating that the large differ-
ence in ROR-t–expressing T cell numbers obtained from 
colons of the adoptively transferred Rag1 KO was caused by 
an expansion of this cell population after transfer. In conclu-
sion, the Treg cell–depleted CD4+ CD45RBlo T cell–induced 
colitis  was  characterized  by  a  greater Th17  cell  response. 
Blockade of IL-10 signaling in T cells led to increased colitis 
severity  in  the Treg  cell–depleted  CD4+  CD45RBlo  colitis 
model, which was also associated with increased numbers of 
Ror-t–positive T cells in the colon.
We next asked whether IL-10 affects the differentiation of 
naive T cells into Th17 cells or, alternatively, whether it acts 
on the antigen-experienced T cells, thereby controlling the 
accumulation of ROR-t–positive T cells. IL-10 did not in-
hibit the differentiation of naive T cells into Th17 cells (Fig. 7 A). 
In contrast, we found that IL-10 decreased Rorc but not Tbx21 
mRNA expression in IL-23–stimulated Treg cell–depleted 
CD4+ CD45RBlo in vitro (Fig. 7 B).
However, it should be noted that we found both elevated 
IFN- and IL-17A mRNA levels in the colon of Rag1 KO 
Figure 6.  Increased Th17 cell cytokine profile in the 
inflamed colon of Rag1 KO mice adoptively transferred 
with Foxp3CD45RBlo cells compared with recipients of 
CD45RBhi cells. (A) mRNA levels of the indicated cytokines 
were measured in total colon extracts of untreated or Rag1 
KO mice adoptively transferred with WT or TG CD45RBhi or 
CD4+Foxp3CD45RBlo (Treg cell–depleted CD45RBlo) cells. mRNA 
levels were normalized to HPRT. Results shown represent the 
mean of four to eight mice per group. The experiments were 
repeated twice with similar results. Mononuclear cells were iso-
lated from the colon of Rag1 KO mice (CD45.1+) adoptively 
transferred with WT or TG CD45RBhi or Treg cell–depleted 
CD45RBlo cells (CD45.2+) 4–8 wk after the transfer. (B) Represen-
tative dot blots for ROR-t and Foxp3 expression (top, Rag1 KO 
mice received CD45RBhi WT or TG cells; bottom, Rag1 KO mice 
received WT or TG Treg cell–depleted CD45RBlo cells). Cells were 
gated on CD45.2+ cells. (C) Number of CD4+ROR-t+ cells recov-
ered from the colon of Rag1 KO recipients of WT or TG Treg cell–
depleted CD45RBlo cells. The experiments were repeated twice 
with similar results. Error bars represent mean ± SEM. *, P < 
0.05; **, P < 0.01.JEM VOL. 208, May 9, 2011 
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through an IL-22–Reg3- pathway. However, it is not clear 
whether the observed difference in Reg3- expression in the 
colon of IL-22 KO Treg cell–depleted CD4+ CD45RBlo  
T cells is causally linked to the reduced intestinal disease or 
just a correlation with the reduced IL-22 levels. Further studies 
are required to address this point.
Interestingly, and in contrast to the CD45RBhi transfer 
colitis model, the colitis induced by the transfer of Treg cell–
depleted CD4+ CD45RBlo T cells was not characterized by 
ulceration of the mucosa, but rather a pronounced thickening 
of the mucosa. Interestingly, IL-22 KO Treg cell–depleted 
CD4+ CD45RBlo T cells did not cause this mucosal thicken-
ing and epithelial hyperplasia (Fig. 8 A and Fig. S7 D).
This difference suggested that IL-22 might be involved 
in the growth or survival of the colon epithelial cells as pre-
viously suggested by others (Pickert et al., 2009). We therefore 
analyzed the proliferation of epithelial cells. First, we assessed 
the BrdU incorporation in epithelial cells by immunohisto-
chemistry: the number of BrdU-positive epithelial cells was 
significantly reduced in the colon of the Rag1 KO mice that 
had received IL-22 KO Treg cell–depleted CD45RBlo colitis 
compared with the controls (Fig. 9, A and B). These results 
were confirmed by the analyses of Ki67 expression and BrdU 
uptake using flow cytometry (Fig. S6). However, the differ-
ences observed did not seem to derive from an effect on cell 
survival because the number of apoptotic epithelial cells as 
detected by TdT-mediated dUTP-biotin nick end labeling 
(TUNEL) staining was not different in the presence or ab-
sence of IL-22 in the donor cells (Fig. 9 C). These results 
suggest that IL-22 from donor cells promotes proliferation 
of the colon epithelium, leading to mucosal hyperplasia 
and thickening.
Morphology of CD45RBhi and Treg cell–depleted CD45RBlo 
CD4+ T cell–driven colitis
When we compared colitis induced by WT CD45RBhi cells 
and Treg cell–depleted CD45RBlo CD4+ T cells, we noticed 
that the architecture of the gut epithelium was highly dis-
torted in the CD45RBhi transfer model (Fig. S7 B). In contrast, 
upon transfer of Treg cell–depleted CD45RBlo, the epithelia 
exhibited less damage but pronounced hyperplasia of the 
epithelium (Fig. 8 D and Fig. S7 B), leading to a significant 
thickening of the mucosal layer compared with the CD45RBhi 
transfer model (Fig. S7 B). IFN- mRNA levels were in-
creased in the colon in the CD45RBhi colitis model, and this 
cytokine might be toxic to the colon epithelium. We there-
fore decided to analyze the involvement of this cytokine. We 
performed adoptive transfers of CD45RBhi CD4+ T cells 
from IFN- KO mice into Rag1 KO mice, and these mice 
lost mass and developed colitis upon transfer (Fig. S7, A and B). 
However, the destruction of the epithelial architecture was 
less severe, and the mucosa was more hyperplastic, causing in-
creased thickening of the mucosal layer, which resembles the 
morphology of colitis induced with Treg cell–depleted CD4+ 
CD45RBlo T cells (Fig. S7, B and D). The expression of IFN- 
was highly reduced in the colitis induced with IFN- KO 
IFN- and IL-22 and similar TNF and IL-17A expression 
compared with WT controls (Fig. 8 E). Of note, in colitis, 
IL-22 can be produced by innate and adaptive immune cells 
(Zenewicz et al., 2008); therefore, IL-22 mRNA expression 
in the IL-22 KO Treg cell–depleted CD4+ CD45RBlo T cell 
transfer model was still detectable but remarkably lower than 
in the mice that received the corresponding WT cells. This 
suggests that during colitis induced by Treg cell–depleted 
CD4+ CD45RBlo T cells, most of the IL-22 expression de-
rived from donor T cells or, less likely, that the T cells influ-
ence the production of IL-22 by the innate cells.
To further characterize the role of IL-22 in the develop-
ment of colitis induced by  Treg cell–depleted CD4+ CD45RBlo 
T cells, we analyzed the expression of downstream molecules 
known to be induced by IL-22 such as Lipocalin 2 (Raffatellu 
et al., 2009), Mucin 1 (Sugimoto et al., 2008), and Reg3- 
(Zheng et al., 2008). Although Lipocalin 2 and Mucin 1 were 
not altered by the absence of IL-22 in donor T cells, Reg3- 
expression was greatly reduced in the colons in the mice that 
received  IL-22  KO  Treg  cell–depleted  CD4+  CD45RBlo  
T cells compared with those that received WT corresponding 
cells (Fig. 8 F). As a C-type lectin antimicrobial molecule, 
Reg3- specifically binds and lyses Gram-positive but not 
Gram-negative bacteria (Cash et al., 2006). Selective alterations 
that disrupt the composition of the commensal flora may ex-
acerbate colitis. These results suggest that the colitis induced with 
Treg cell–depleted CD4+ CD45RBlo T cells might develop 
Figure 7.  IL-10 does not inhibit the differentiation of naive T cells 
into Th17 cells but decreases Rorc expression in the Treg cell–depleted 
CD45RBlo T cells in vitro. (A) Naive T cells were cultured for 3 d in the 
presence of 0.5 ng/ml TGF-1, 10 ng/ml IL-6, and 20 ng/ml IL-23. 100 ng 
recombinant IL-10 was added as indicated. Rorc mRNA levels normalized 
to HPRT are shown. IL-17A expression was measured using flow cytom-
etry. (B) CD4+Foxp3 RFPCD45RBlo cells were sorted using FACS and were 
in vitro stimulated with IL-23 for 6 h in the presence of different concen-
trations of recombinant IL-10 as indicated. Rorc and Tbx21 mRNA levels 
normalized to HPRT are shown. Results are representative of at least two 
independent experiments. Error bars represent mean ± SEM.1036 IL-10 signals in T cells protect against colitis | Kamanaka et al.
not Th1 cells are predominant in colitis developed with 
IFN-  KO  CD45RBhi  cells.  In  conclusion,  these  results 
suggested that the absence of IFN- or high expression of 
CD45RBhi T cells compared with the corresponding WT cells 
(Fig. S7 C). In contrast, Th17 cytokines such as IL-22, IL-17A, 
and IL-17F were highly elevated, suggesting that Th17 but 
Figure 8.  Intestinal pathology induced by CD25CD45RBlo T cells is dependent on T cell–derived IL-22. CD4+CD25CD45RBlo (Treg cell–depleted 
CD45RBlo) cells from C57BL/6 (WT) or Il22/ mice (IL-22 KO) were adoptively transferred into Rag1 KO mice. (A) Percent change from initial mouse 
weight 13 wk after cell transfer. (B) Selected images from endoscopic colonoscopies performed on the mice at 13 wk after transfer (left) and endoscopic 
colitis scores (right). (C) Graph represents colon length at 14 wk after transfer. (D) Colon tissue sections were examined by hematoxylin and eosin staining. 
Shown are representative colon tissues. Colon sections were scored according to the Materials and methods for chronicity (top) and disease activity  
(bottom). The boxed areas are shown at higher magnification on the right. Bars: (left) 1,000 µm; (right) 400 µm. (E) mRNA levels of different cytokines in 
the distal colon of the mice. (F) mRNA levels of the indicated IL-22–regulated genes. Each dot represents one mouse; horizontal bars indicate the mean. 
Results are representative of two experiments. *, P < 0.05; **, P < 0.01; ***, P < 0.001.JEM VOL. 208, May 9, 2011 
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T cells is functional after IL-10 stimulation as Stat3 phos-
phorylation occurs both in CD45RBhi and CD45RBlo CD4+ 
T cells (Fig. S1). Together, these results suggested the existence 
of functional IL-10 signaling in mouse CD4 T cells.
The adoptive transfer model has been frequently used as a 
model of colitis, which resembles some features of Crohn’s 
disease. It has been shown previously that nTreg cells could 
protect against colitis induced by CD45RBhi CD4 T cells, and 
it was also found that IL-10 is not required for this suppres-
sion (Asseman et al., 2003). Interestingly, however, normal 
mice that received anti–IL-10R antibody developed colitis 
(Asseman et al., 2003), which suggested that cells other than 
CD45RBhi and nTreg T cells may participate in the develop-
ment of colitis. Our current results are in line with these find-
ings and suggest that Treg cell–depleted CD4+ CD45RBlo  
T cells are responsible for colitis under conditions where IL-10 
is  neutralized.  In  addition, TG Treg  cell–depleted  CD4+ 
CD45RBlo T cells are not well controlled by nTreg cells in 
vivo and in vitro in the presence of IL-23 (Figs. 3 and 4). Thus, 
blockade  of  IL-10  signaling  might  render Treg  cell–depleted 
CD45RBlo CD4 T cells resistant to suppression by nTreg cells 
and thus make recipient Rag1 KO mice susceptible to colitis.
The Treg cell–depleted CD4+ CD45RBlo T cell population 
also contains IL-10–producing T cells, and it would therefore 
also be possible that blockade of IL-10 signaling led to a re-
duced number of IL-10–secreting cells. However, we could 
not find a significant difference in IL-10–producing cells upon 
transfer of Treg cell–depleted CD4+ CD45RBlo T cells into 
Rag1 KO mice (WT, 1.4 ± 0.34% vs. TG, 2 ± 0.3%), indicat-
ing that IL-10 signaling is dispensable for the generation of 
IL-10–producing T cells, which is in line with a previous pub-
lication (Maynard et al., 2007). Since the preparation of this 
manuscript, an interesting manuscript was published that showed 
that IL-10 inhibits the function of nTreg cells by repressing Foxp3 
expression (Murai et al., 2009). Therefore, IL-10R KO Treg 
cells were not able to suppress CD4+ CD45RBhi T cells upon 
transfer into an immune-deficient host (Murai et al., 2009). 
The results in our model are primarily directed at an additional 
inhibitory function of IL-10 on the pathogenic effector/mem-
ory cells. In contrast to the study by Murai et al. (2009), we 
could not find any defect in the suppressive capacity of nTreg 
cells with blocked IL-10 signaling in vivo or in vitro. Differ-
ences in the mouse model used may account for these differ-
ent results. Additionally, current publications suggest a major 
role of the microbial milieu for the development of colitis 
(Round and Mazmanian, 2009; Nell et al., 2010), and there-
fore differences in the microbial milieu in the different animal 
facilities might also contribute to our different result.
Throughout our analysis, we also found that CD45RBhi 
cells and Treg cell–depleted CD45RBlo CD4+ T cells exhibit 
different characteristics when adoptively transferred into Rag1 
KO mice (Fig. S8). CD45RBhi cells proliferate more aggressively 
(Fig. S4 B) and induce colitis faster than Treg cell–depleted 
CD45RBlo cells. Additionally, the CD4 T cell effector response 
found in colitis developed by CD4+ CD45RBhi T cells was 
characterized by increased Th1 cytokines compared with Treg 
Th17 cytokines might result in less destruction of epithelial 
architecture but instead may lead to mucosal hyperplasia of 
the colon epithelium.
DISCUSSION
In this study, we have analyzed the role of IL-10 signaling in 
CD4 T cells by generating dominant-negative IL-10R TG 
mice. Our results indicated that direct IL-10 signals control 
colitis development, in particular when caused by the Treg 
cell–depleted CD45RBlo memory/effector CD4 T cell pop-
ulation. This has also spotlighted characteristic differences in 
the mechanism of colitis development mediated by CD45RBhi 
cells or Treg cell–depleted CD45RBlo CD4+ T cells.
It was previously reported by others that activation could 
reduce the expression of IL-10R1 (IL-10R) mRNA in 
human T cell clones (Liu et al., 1994). We found that although 
expression of mouse IL-10R is reduced upon activation, it 
recovered after 24–48 h both at the level of mRNA (not de-
picted) and cell surface protein expression (Fig. S1). In addition, 
the surface expression of IL-10R is detectable at any time of 
activation by flow cytometry. The IL-10R on the surface of 
Figure 9.  IL-22 promotes cell proliferation in the colon. 
CD4+CD25CD45RBlo (Treg cell–depleted CD45RBlo) cells from C57BL/6 
(WT) or Il22/ (IL-22 KO) mice were adoptively transferred into Rag1 KO 
mice. At 14 wk after transfer, 4 h before euthanization, mice were injected 
with BrdU. Colon sections were stained by immunohistochemistry with an 
antibody to BrdU. (A) Selected micrographs from two individual mice. 
Bars: (left) 250 µm; (right) 50 µm. (B) Quantification of the mean number 
of BrdU+ cells per field for the sections in A. (C) Colonic tissue sections 
were also subjected to TUNEL staining. TUNEL+ cells per crypt were quan-
tified. Each dot represents one mouse; horizontal bars indicate the mean 
(BrdU: WT, n = 10; and KO, n = 10; TUNEL: WT, n = 7; and KO, n = 8).  
Results were confirmed twice using BrdU and Ki67 staining of colon epi-
thelial cells and flow cytometry (shown in Fig. S6). **, P < 0.01.1038 IL-10 signals in T cells protect against colitis | Kamanaka et al.
has been reported to have dual proinflammatory and anti-
inflammatory functions. IL-22 is required for skin inflamma-
tion and thickening in the IL-23–dependent model of psoriasis 
(Zheng et al., 2007; Ma et al., 2008), whereas it is protective 
in a hepatitis model (Zenewicz et al., 2007). The hyperprolif-
erative pathology in psoriasis is comparable with the similar 
outcome in the Treg cell–depleted CD45RBlo model. In con-
clusion, our results suggest that overproduction of IL-22, which 
is the case in the Treg cell–depleted CD45RBlo colitis model, 
results in epithelial hyperplasia, which causes greater intestinal 
pathology and weight loss. However, we found that IFN- is 
also decreased in the absence of T cell–derived IL-22 in the 
Treg cell–depleted CD45RBlo colitis model, and we therefore 
cannot exclude a possible contribution of IFN- to the 
pathogenesis in these settings. Further investigation on how 
this dual functionality of IL-22 is achieved should be eluci-
dated and will lead to a better understanding of IBD. Our re-
sults also point to the complexity of using IL-22 antagonism 
or agonism in the therapy of inflammatory diseases.
In summary, our findings point to a fundamental differ-
ence in the pathological mechanisms that underlie colitis in-
duced by CD45RBhi and Treg cell–depleted CD45RBlo CD4+ 
T cells, as the latter requires direct IL-10 signaling to be regu-
lated by nTreg cells. It is noteworthy that human Crohn’s dis-
ease may well result from the action of memory/effector (Treg 
cell–depleted CD45RBlo) T cells rather than or as well as 
CD45RBhi CD4+ T cells. In any event, we believe that this 
new model for IBD provides a useful additional alternative to 
the already existing portfolio of IBD models, and further in-
vestigation of this model might contribute to the search for a 
cure or better treatment of human IBD.
MATERIALS AND METHODS
Mice and reagents. C57BL/6 mice and CD45.1 mice were purchased 
from the National Cancer Institute. IL-10, IFN-, and Rag1 KO mice were 
obtained from the Jackson Laboratory. Foxp3 knockin reporter (FIR) mice 
(Wan and Flavell, 2005), IL-17A KO (Nakae et al., 2002), and IL-22 KO 
(Zenewicz et al., 2007) mice have been described previously. Our Rag1 KO 
colony tested PCR positive for Helicobacter hepaticus (Shames et al., 1995). All 
animal procedures were approved by the Institutional Animal Care and Use 
Committee of Yale University. Recombinant IL-10 and antibodies to IL-10R, 
B220, CD4, CD8 CD11b, and CD11c were purchased from BD.
Generation of CD4dnIL-10R mice. The mouse IL-10R gene frag-
ment truncated at proline 265 just beneath the transmembrane region was 
cloned by PCR from cDNA generated from mouse B cell mRNA. The 
primer of this reaction was flanked with SalI sites, and the fragment was sub-
cloned into the SalI site of plasmid CD4 promoter vector p37.1 (Gorelik and 
Flavell, 2000). The truncated form of IL-10R has 10 residues of read 
through amino acids at the carboxy terminal, which derive from the vector 
sequence before a termination codon. To generate TG mice, the CD4dnIL-
10R fragment containing CD4 promoter, IL-10R, and polyadenylation 
sequence was excised by NotI, purified, and injected into (C57BL/6xC3H)F1-
fertilized eggs. Founder mice were identified using PCR and backcrossed at 
least 12 times onto the C57BL/6 background for further experiments.
Western blot. For the analysis of Stat3 phosphorylation, total cell lysates of 
the indicated cell populations were separated on a 10% SDS gel, transferred 
to a polyvinylidene fluoride membrane (Millipore) and probed with anti–
phospho-Stat3 (Tyr705) antibody (Cell Signaling Technology). The membrane 
cell–depleted CD4+ CD45RBlo T cell–induced colitis, which 
was characterized more by Th17 cytokines. The blockade of 
IL-10  signaling  selectively  affected  the  Treg  cell–depleted 
CD45RBlo T cells, rendering them more pathological and 
enabling them to escape from control by nTreg cells. We also 
analyzed whether IL-10 inhibits the in vitro differentiation of 
naive T cells into Th17. However, we could not find any sig-
nificant inhibitory effect of IL-10 on the mRNA expression 
of Rorc, the gene encoding ROR-t, or on the frequency of 
IL-17A–producing T cells generated from naive CD4T cells. 
In contrast, we found that IL-10 decreased, in a dose-dependent 
manner, the mRNA expression of Rorc but not Tbx21, the 
gene encoding T-bet, in IL-23–stimulated CD45RBlo T cells 
in vitro (Fig. 7). These data strengthen our in vivo data and 
suggest again that IL-10 is particularly important to control 
the antigen-experienced inflammatory cells.
Histologically, the CD45RBhi colitis model was charac-
terized  by  ulceration,  in  contrast  to  the Treg  cell–depleted 
CD45RBlo colitis model, which instead showed epithelial hy-
perplasia and thickening of the mucosa. IL-22 was found to 
be protective in the CD45RBhi colitis model (Zenewicz et al., 
2008) as well as in an ulcerative colitis model (Sugimoto et al., 
2008) and to ameliorate inflammation during colon infection 
(Zheng et al., 2008). However, in contrast, in this study, we 
found a pathogenic role of this cytokine in the colitis model 
induced by Treg cell–depleted CD4+ CD45RBlo T cells.
High Th1 cytokines such as IFN- in the colon might be 
toxic to the colonic epithelium and might exacerbate disease, 
leading to the epithelial erosion and ulceration that character-
izes the CD45RBhi model. Our finding that colitis induced 
with T cells from IFN- KO mice showed less epithelial 
damage supports this hypothesis. In line with this idea, we 
found that IL-17A KO CD45RBhi CD4+ T cells cause more 
severe disease upon transfer into Rag1 KO recipients compared 
with WT.  Interestingly,  this  was  associated  with  increased 
IFN-–producing T cells and more severe ulceration in the 
mice receiving WT cells (O’Connor et al., 2009). In this con-
text, it is possible that Th17 cytokines like IL-22 might protect 
the epithelium in the presence of Th1 cytokines. In contrast, 
in the Treg cell–depleted CD45RBlo CD4+ T cell adoptive 
transfer, IFN- expression in the colon was lower and Th17 
cytokine mRNA levels, including IL-22 expression, were higher 
than in CD45RBhi model.
As the colonic epithelia were hyperplastic and the muco-
sal layer thickened in the Treg cell–depleted CD45RBlo trans-
fer model, the Th17 cytokine environment might be involved 
in the regeneration of epithelial cells. IL-22 might act on epi-
thelial cells to promote proliferation or survival (Pickert et al., 
2009). This seems to be beneficial in the CD45RBhi model 
through repair or prevention of epithelial erosion and ulcer-
ation. The observation that IL-22 KO Treg cell–depleted 
CD45RBlo T cells showed milder intestinal pathology and 
less hyperplasia of the epithelia supports the hypothesis that, 
in contrast, IL-22, by precisely the same mechanism, might 
also lead to epithelial hyperproliferation and therefore could 
play a pathogenic role. Accordingly, in the literature, IL-22 JEM VOL. 208, May 9, 2011 
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to severe epithelial hyperplasia and mucin depletion; grade 4, marked inflam-
matory cell infiltrates that were often transmural and associated with crypt 
abscesses and occasional ulceration, with marked epithelial hyperplasia,   
mucin depletion, and loss of intestinal glands. For the IL-22 experiments, 
chronicity (the degree of chronic inflammation) and activity (degree of epi-
thelial injury) were scored separately.
Quantitative PCR. RNA was extracted with TRIZOL reagent, and cDNA 
was synthesized by Superscript II reverse-transcriptase according to the man-
ufacturer’s protocols (Invitrogen). The real-time PCR system (model 7500; 
Applied Biosystems) was used for quantitative PCR. The sequence of the 
probe to detect IFN- was 5-FAM-TTTGAGGTCAACAACCCACAG-
GTCCA-BHQ-1-3with  the  primers,  5-CCTTTTCCGCTTCCTG-
AGG-3 and 5-CTGGTGAAAAGGACCTCTCG-3. The primer probe 
sets  for  IL-10R  (Mm00434151_m1),  IL-17A  (Mm00434291_m1), 
IL-17F  (Mm00521423_m1),  IL-22  (Mm00444241_m1),  and  G-CSF 
(Mm00438334_m1) were purchased from Applied Biosystems. Hypoxan-
thine phosphoribosyltransferase (HPRT) was used as an internal reference 
and measured with the primers 5-CTGGTGAAAAGGACCTCTCG-3 
and  5-TGAAGTACTCATTATAGTCAAGGGCA-3  with  the TaqMan 
probe  5-FAM-TGTTGGATACAGGCCAGACTTTGTTGGAT-BHQ-1-3. 
Relative expression of cytokines normalized to HPRT was calculated using 
the Ct method. The relative fold changes of expression are presented, 
where control samples are set to an expression index of 1.
Statistical analysis. Survival rate was analyzed by logrank test, and histol-
ogy score was determined by the Mann-Whitney U test. Other data were 
analyzed by the Student’s t test.
Online supplemental material. Fig. S1 shows expression of IL-10R in 
murine CD4 T cells. Fig. S2 shows that IL-6–mediated Stat3 activation is not 
abrogated in TG CD4 T cells. Fig. S3 characterizes the TG Foxp3CD45RBlo 
cells before adoptive transfer. Fig. S4 shows the competitive adoptive trans-
fer of WT and TG CD45RBhi or CD25CD45RBlo cells into Rag1 KO 
mice.  Fig.  S5  shows  that  induction  of  colitis  by  CD25CD45RBlo  cells 
is dependent on T cell–derived IL-22 but not IL-17A. Fig. S6 shows in-
creased epithelial cell proliferation in Rag1 KO mice receiving IL-22 KO 
CD25CD45RBlo cells using flow cytometry. Fig. S7 characterizes colitis 
induced by the transfer of IFN- KO CD45RBhi T cells into Rag1 KO 
mice. Fig. S8 is a summary of the colitis developed by CD45RBhi and Treg 
cell–depleted CD45RBlo T cells. Online supplemental material is available at 
http://www.jem.org/cgi/content/full/jem.20102149/DC1.
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